"From here, while we anticipate shares to be down modestly, we do not think the Street was assigning any meaningful value to the asset and see limited downside given the company's current valuation," JPMorgan analyst Chris Schott wrote in a note to clients Monday
We will work with you to make sure that you feel confident administering these medications to yourself prior to starting treatment
Non-selective profile distinct from next generation analogues (afamelanotide MC1R selective, bremelanotide MC4R preferential)
Regional considerations affect transport planning
Periodic monitoring of copper and zinc levels is reasonable for extended use protocols, as the copper-zinc balance can shift with prolonged copper supplementation through any delivery mechanism
Generally reserved for patients who do not respond to, or cannot tolerate psychostimulants (Cortese et al, 2018